Verapamil bewahrt wohl Betazell-Restfunktion bei neuem Typ-1-Diabetes
Human clinical trial reveals verapamil as an effective Type 1 diabetes therapy - News | UAB
Verapamil shows beneficial effect on the pancreas in children with newly-diagnosed type 1 diabetes
Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes | Nature Communications
Proteomics Reveals How Drug Delays Early Onset Type 1 Diabetes | PNNL
Verapamil remt ziekteprogressie diabetes type 1' | NTvG
Verapamil Slows Type 1 Diabetes in Newly Diagnosed Children/Teens
Typ-1-Diabetes | Verapamil erhält länger die Betazellfunktion bei neu manifestiertem Typ-1-Diabetes | springermedizin.de
Verapamil shows potential as a long-term oral treatment for type 1 diabetes
Verapamil schützt Betazellen | PZ – Pharmazeutische Zeitung
Verapamil bei Typ-1-Diabetes? - Pharmakotherapie
Verapamil In Type 1 Diabetes | ATIC
Diabetology | Free Full-Text | Verapamil and Its Role in Diabetes
Blood pressure medicine shows potential as type 1 diabetes cure
Drug Verapamil shown to slow T1D progression in newly diagnosed
Betazellfunktion aufrechterhalten: Blutdrucksenker als mögliche Therapie bei Kindern und Jugendlichen
Verapamil and beta cell function in adults with recent-onset type 1 diabetes | Nature Medicine
Study shows the beneficial effect of verapamil in children with newly-diagnosed type 1 diabetes
Blood Pressure Medication 'Verapamil' Stimulates Insulin Production | Drug Discovery And Development
Evaluating the antidiabetic effects of R-verapamil in type 1 and type 2 diabetes mellitus mouse models | PLOS ONE
Blood pressure drug verapamil restores beta cell function in new-onset type 1 diabetes - Diabetes
Verapamil partially preserves C-peptide levels among youths with type 1 diabetes
